Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...

Proteins are central to cellular function, yet traditional proteomics methods—including mass spectrometry-based and affinity-based approaches—face challenges in resolving proteoforms, the distinct ...

Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...

Every year, millions of newborns undergo routine screening as a preventive strategy to detect inherited disorders before ...

Bulk harvest release testing for adventitious viruses is an integral part of biosafety for manufacturing biopharma products. Finding a testing strategy that works for diverse biologics modalities ...

Next-generation DNA sequencing (NGS)—the engine behind personalized medicine, cancer diagnostics, infectious disease tracking, and cutting-edge genetic research—is increasingly at risk of cyberattacks ...

The Advances in Genome Biology and Technology (AGBT) meeting celebrated its 25 th anniversary in sunny Marco Island, Florida, with the customary mix of big name speakers addressing researchers and ...

Located on the Buffalo Niagara Medical Campus and the first next-generation sequencing service provider in the region, UB's Genomics and Bioinformatics Core Facility provides high-quality services ...